Predictive factors for the benefit of perioperative FOLFOX for resectable liver metastasis in colorectal cancer patients (EORTC Intergroup Trial 40983)

Ann Surg. 2015 Jan;261(1):e28-9. doi: 10.1097/SLA.0000000000000419.

Authors

Lilian Schwarz¹, Pierre Michel, Michel Scotté

Affiliation

¹ Department of Digestive Surgery Department of Digestive Oncology Department of Digestive Surgery Rouen University Hospital Rouen, France [email protected].

PMID: 24263311
DOI: 10.1097/SLA.0000000000000419

No abstract available

Publication types

Letter
Comment

MeSH terms

Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
Colorectal Neoplasms / pathology*
Female
Humans
Liver Neoplasms / drug therapy*
Liver Neoplasms / secondary*
Male
Perioperative Care*